Related Experiment Video
Updated: Apr 25, 2026
06:41
Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research
Published on: October 20, 2023
4.7K
Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms
Marc S Weinberg1, Sarah Nicolson2, Aadra P Bhatt3
1Gene Therapy Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Journal of Virology
|August 22, 2014
Summary
Inhibiting macropinocytosis affects recombinant adeno-associated virus (rAAV) entry into cells differently depending on the cell type. This discovery offers a new way to control rAAV gene therapy delivery.
Area of Science:
- Virology
- Cell Biology
- Gene Therapy
Background:
- Recombinant adeno-associated virus (rAAV) is a key vector for gene therapy, but understanding its entry mechanisms is crucial for improving efficacy and safety.
- Existing research on rAAV entry pathways shows variability, suggesting multiple entry routes may exist.
- Targeted delivery of rAAV vectors is needed to minimize toxicity and immune responses.
Purpose of the Study:
- To investigate the role of macropinocytosis in rAAV transduction across different cell types.
- To determine if inhibiting macropinocytosis can be used to modulate rAAV vector targeting and gene expression.
- To explore the potential for cell-specific control of rAAV entry and trafficking.
Main Methods:
- Tested the effect of macropinocytosis inhibitors (cytochalasin D, EIPA) on rAAV transduction in HeLa and hepatocellular carcinoma cell lines (HepG2, Huh7).
- Investigated the impact of macropinocytosis inhibition on viral binding, promoter activity, and different rAAV serotypes and genome types.
- Utilized CDC42 inhibitor (ML141) and PAK1 siRNA knockdown, and performed microscopy to assess rAAV nuclear entry.
- Evaluated in vivo effects in mouse liver and heart tissues.
Main Results:
- Macropinocytosis inhibition blocked rAAV transduction in HeLa cells but enhanced it significantly in HepG2 and Huh7 cells (up to 10-fold).
- Enhanced transduction in hepatocellular cells was not due to increased viral binding or promoter activity and applied to multiple rAAV serotypes and genome types.
- Microscopy showed faster nuclear entry of rAAV in HepG2 cells upon macropinocytosis inhibition.
- In vivo studies demonstrated enhanced liver transduction but inhibited heart transduction in mice.
Conclusions:
- rAAV utilizes distinct entry pathways that are dependent on the host cell type.
- Inhibiting macropinocytosis provides a cell-specific method to enhance or block rAAV transduction, with implications for in vivo targeting.
- This finding offers a novel strategy for controlling vector delivery and potentially unifying divergent accounts of rAAV cellular entry mechanisms.
More Related Videos
Related Concept Videos
02:33Retroviruses
11.9K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
11.9K
01:10Retrovirus Life Cycles
42.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K
00:57Viral Recombination
22.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
22.1K
01:51Mechanisms of Retrovirus-induced Cancers
5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K